These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 18971303)

  • 1. Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.
    Sendid B; Dotan N; Nseir S; Savaux C; Vandewalle P; Standaert A; Zerimech F; Guery BP; Dukler A; Colombel JF; Poulain D
    Clin Vaccine Immunol; 2008 Dec; 15(12):1868-77. PubMed ID: 18971303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease.
    Standaert-Vitse A; Jouault T; Vandewalle P; Mille C; Seddik M; Sendid B; Mallet JM; Colombel JF; Poulain D
    Gastroenterology; 2006 May; 130(6):1764-75. PubMed ID: 16697740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida albicans colonization and ASCA in familial Crohn's disease.
    Standaert-Vitse A; Sendid B; Joossens M; François N; Vandewalle-El Khoury P; Branche J; Van Kruiningen H; Jouault T; Rutgeerts P; Gower-Rousseau C; Libersa C; Neut C; Broly F; Chamaillard M; Vermeire S; Poulain D; Colombel JF
    Am J Gastroenterol; 2009 Jul; 104(7):1745-53. PubMed ID: 19471251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
    Vandewalle-El Khoury P; Colombel JF; Joossens S; Standaert-Vitse A; Collot M; Halfvarson J; Ayadi A; Landers CJ; Vermeire S; Rutgeerts P; Targan SR; Chamaillard M; Mallet JM; Sendid B; Poulain D
    Am J Gastroenterol; 2008 Apr; 103(4):949-57. PubMed ID: 18047546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.
    Sendid B; Quinton JF; Charrier G; Goulet O; Cortot A; Grandbastien B; Poulain D; Colombel JF
    Am J Gastroenterol; 1998 Aug; 93(8):1306-10. PubMed ID: 9707056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens.
    Müller S; Schaffer T; Flogerzi B; Seibold-Schmid B; Schnider J; Takahashi K; Darfeuille-Michaud A; Vazeille E; Schoepfer AM; Seibold F
    Gut; 2010 Nov; 59(11):1493-500. PubMed ID: 20682699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeasts: neglected pathogens.
    Poulain D; Sendid B; Standaert-Vitse A; Fradin C; Jouault T; Jawhara S; Colombel JF
    Dig Dis; 2009; 27 Suppl 1():104-10. PubMed ID: 20203505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans.
    Schaffer T; Müller S; Flogerzi B; Seibold-Schmid B; Schoepfer AM; Seibold F
    Inflamm Bowel Dis; 2007 Nov; 13(11):1339-46. PubMed ID: 17636567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
    Schoepfer AM; Flogerzi B; Seibold-Schmid B; Schaffer T; Kun JF; Pittet V; Mueller S; Seibold F
    Am J Gastroenterol; 2009 Oct; 104(10):2508-16. PubMed ID: 19532127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-glycan antibodies establish an unexpected link between C. albicans and Crohn disease].
    Sendid B; Jouault T; Vitse A; Fradin C; Colombel JF; Poulain D
    Med Sci (Paris); 2009 May; 25(5):473-81. PubMed ID: 19480828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.
    Hadrich I; Vandewalle P; Cheikhrouhou F; Makni F; Krichen MS; Sendid B; Standaert-Vitse A; Ayadi A; Poulain D
    Scand J Gastroenterol; 2007 Jun; 42(6):717-25. PubMed ID: 17505994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
    Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
    Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of circulating Candida albicans mannan and antimannan antibodies: useful for diagnosis of deep seated candidiasis].
    Eloy O; Tabella C; Harzic M; Pina P; Allouch P; Pangon B; Bedos JP; Ghnassia JC
    Ann Biol Clin (Paris); 2002; 60(6):711-4. PubMed ID: 12446238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced IgE response to Candida albicans in postoperative invasive candidiasis.
    Savolainen J; Rantala A; Nermes M; Lehtonen L; Viander M
    Clin Exp Allergy; 1996 Apr; 26(4):452-60. PubMed ID: 8732243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Candida-specific anti-mannan antibodies precede invasive candidiasis in patients undergoing myelo-ablative chemotherapy.
    Verduyn Lunel FM; Donnelly JP; van der Lee HA; Blijlevens NM; Verweij PE
    Clin Microbiol Infect; 2009 Apr; 15(4):380-6. PubMed ID: 19191788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating beta (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis.
    Kondori N; Edebo L; Mattsby-Baltzer I
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):344-50. PubMed ID: 15013986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of candidaemia in patients with and without underlying haematological disease.
    Arendrup MC; Bergmann OJ; Larsson L; Nielsen HV; Jarløv JO; Christensson B
    Clin Microbiol Infect; 2010 Jul; 16(7):855-62. PubMed ID: 20002683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interest of serologic markers in inflammatory bowel disease. About 105 cases].
    Fekih M; Ben Hlima S; Zitouni M; Matri S; Boubaker J; Makni S; Azza F
    Tunis Med; 2007 Oct; 85(10):821-8. PubMed ID: 18236802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.